LSTA 8-K 2026-10-14

LISATA THERAPEUTICS, INC. (LSTA) 8-K dated 2026-10-14 — accession 0001140361-26-039602. This URL is the filing, not the LSTA hub.

LISATA THERAPEUTICS, INC. (LSTA) is a biotechnology company listed on US.

LISATA THERAPEUTICS, INC. filed a 8-K on 2026-10-14. Accession 0001140361-26-039602.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LSTA revenue for 2025-12-31 was $170.0K. Net income was -$16.6M. Revenue was down 83.0% from 2024-12-31 to 2025-12-31. LSTA currently screens at market cap $31.7M.

Not investment advice. The LSTA SEC hub lists recent forms. The stock page is the research view.